Emicizumab
roche
[]
1/3 of thrombosis in emicizumab in eudravigilence dataset assoc w use of fviia, feiba, fviii. lower rates of bleeding events compared to ehl but increased risk thrombosis. #ash2022 
Peds & AYA Hematologist, #APD @OCHBuffalo @WNYBloodCare @RoswellPark who ? hemostasis and thrombosis, #MedEd, @buffalobills. All opinions are my own.